2025 Bronze Sponsor
IBA Dosimetry GmbH
IBA Dosimetry GmbH is a leading provider of integrated and independent Quality Assurance (QA) solutions for Radiation Therapy, Proton Therapy, and Medical Imaging. For over 50 years, IBA Dosimetry has been dedicated to maximizing accuracy, efficiency, and patient safety through innovative products and service.
With the acquisitions of Modus Medical Devices Inc. (branded IBA QUASAR), in 2022 and RADCAL Corporation in 2024, IBA Dosimetry has diversified its portfolio to include advanced tools for MR image guidance, motion management and diagnostic imaging, reinforcing its strong position in the industry.
2025 ASM Supporter
Ontario Institute for Cancer Research
The OICR Imaging Program is pleased to support the COMP Annual Scientific Meeting.
The mission of the Imaging Program is to build the capability in Ontario to accelerate translation of research findings and development of new imaging techniques and probes of cancer into clinical practice through the critical stages. For more information about the OICR Imaging Program, visit our website at https://oicr.on.ca/programs/imaging/
You can find information about opportunities to collaborate with the Imaging Program on our website at https://oicr.on.ca/research/collaborative-research-resources/